Nuveen Asset Management LLC Raises Stock Holdings in Oak Street Health, Inc. (NYSE:OSH)

Nuveen Asset Management LLC increased its position in Oak Street Health, Inc. (NYSE:OSH – Get Rating) by 70.2% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 516,049 shares of the company’s stock after acquiring an additional 212,822 shares during the period. Nuveen Asset Management LLC owned approximately 0.21% of Oak Street Health worth $12,654,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Capital Research Global Investors raised its stake in Oak Street Health by 61.0% in the 1st quarter. Capital Research Global Investors now owns 11,852,080 shares of the company’s stock worth $318,584,000 after acquiring an additional 4,491,941 shares during the last quarter. Vanguard Group Inc. raised its stake in Oak Street Health by 1.8% in the 1st quarter. Vanguard Group Inc. now owns 10,238,348 shares of the company’s stock worth $275,207,000 after acquiring an additional 181,216 shares during the last quarter. Eminence Capital LP raised its stake in shares of Oak Street Health by 32.7% during the 2nd quarter. Eminence Capital LP now owns 3,615,541 shares of the company’s stock valued at $59,439,000 after buying an additional 891,114 shares during the last quarter. Riverbridge Partners LLC raised its stake in shares of Oak Street Health by 8.1% during the 3rd quarter. Riverbridge Partners LLC now owns 2,728,744 shares of the company’s stock valued at $66,909,000 after buying an additional 203,576 shares during the last quarter. Finally, MFN Partners Management LP raised its stake in shares of Oak Street Health by 259.3% during the 2nd quarter. MFN Partners Management LP now owns 2,335,329 shares of the company’s stock valued at $38,393,000 after buying an additional 1,685,329 shares during the last quarter. Hedge funds and other institutional investors own 92.04% of the company’s stock.

Analyst Ratings Changes

OSH has been the subject of a number of recent research reports. JPMorgan Chase & Co. lowered Oak Street Health from an “overweight” rating to a “neutral” rating and lifted their price objective for the company from $35.00 to $39.00 in a research note on Thursday, February 23rd. Canaccord Genuity Group reduced their price objective on Oak Street Health from $32.00 to $27.00 in a research note on Wednesday, November 9th. Piper Sandler lowered Oak Street Health from an “overweight” rating to a “neutral” rating and reduced their price objective for the company from $47.00 to $39.00 in a research note on Wednesday, February 8th. UBS Group dropped their target price on Oak Street Health from $28.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 6th. Finally, Sanford C. Bernstein cut Oak Street Health from an “outperform” rating to a “market perform” rating and raised their target price for the company from $35.00 to $39.00 in a research report on Wednesday, February 15th. One equities research analyst has rated the stock with a sell rating, thirteen have given a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, Oak Street Health presently has a consensus rating of “Hold” and a consensus target price of $32.67.

Oak Street Health Price Performance

Shares of Oak Street Health stock opened at $35.56 on Wednesday. The stock has a market cap of $8.68 billion, a P/E ratio of -16.09 and a beta of 2.22. The stock’s 50 day simple moving average is $30.09 and its 200-day simple moving average is $25.34. Oak Street Health, Inc. has a 1-year low of $13.29 and a 1-year high of $35.65.

Oak Street Health (NYSE:OSH – Get Rating) last released its quarterly earnings results on Tuesday, February 28th. The company reported ($0.56) EPS for the quarter, beating the consensus estimate of ($0.58) by $0.02. The firm had revenue of $577.70 million for the quarter, compared to analyst estimates of $571.26 million. Oak Street Health had a negative net margin of 23.57% and a negative return on equity of 1,883.59%. The business’s revenue for the quarter was up 46.6% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.62) EPS. As a group, research analysts expect that Oak Street Health, Inc. will post -1.6 EPS for the current fiscal year.

Insider Activity

In other news, CFO Timothy M. Cook sold 1,480 shares of Oak Street Health stock in a transaction that occurred on Thursday, February 2nd. The shares were sold at an average price of $28.49, for a total transaction of $42,165.20. Following the sale, the chief financial officer now owns 1,357,241 shares of the company’s stock, valued at approximately $38,667,796.09. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Oak Street Health news, CFO Timothy M. Cook sold 1,480 shares of the business’s stock in a transaction that occurred on Thursday, February 2nd. The stock was sold at an average price of $28.49, for a total value of $42,165.20. Following the sale, the chief financial officer now owns 1,357,241 shares of the company’s stock, valued at $38,667,796.09. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Brian Clem sold 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 3rd. The shares were sold at an average price of $24.02, for a total value of $120,100.00. Following the completion of the sale, the chief operating officer now directly owns 546,337 shares in the company, valued at approximately $13,123,014.74. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 624,997 shares of company stock valued at $21,058,464. 11.40% of the stock is currently owned by company insiders.

Oak Street Health Profile

(Get Rating)

Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.